Bevacizumab for the treatment of recurrent glioblastoma multiforme [ID80]

  • Discontinued
  • GID-TAG413

Documents

Documents created during the development process.

Glioblastoma - bevacizumab: final scope

Glioblastoma - bevacizumab: final matrix

Glioblastoma - bevacizumab: Institute's response to consultee and commentator comments on the draft scope

Glioblastoma - bevacizumab: Institute's response to consultee and commentator comments on the provisional matrix